This topical gel formulation is a compounded blend of estriol and estradiol, each constituting 50% of the formulation, with concentrations ranging from 0.05 to 0.5 mg/gm. It also contains progesterone in concentrations ranging from 5 to 50 mg/gm. This unique combination is designed to address a variety of health conditions, including menopausal symptoms, endometriosis, uterine fibroids, and premenstrual syndrome (PMS). It has also been found to potentially reduce the risk of endometrial cancer.

The gel is dispensed through a pump mechanism, which allows for easy and precise application on the skin. The active ingredients are absorbed through the skin and into the bloodstream, providing targeted treatment. The gel-like consistency ensures a smooth application process.

It is crucial to note that this formulation is not suitable for pregnant women or women who are breastfeeding. The active ingredients may cause harm to the fetus or pass into breast milk, potentially causing harm to the infant.

When used as directed, this formulation has been shown to effectively alleviate symptoms such as hot flashes, night sweats, and vaginal dryness. It may also contribute to a reduced risk of developing endometrial cancer and uterine fibroids.

If you have any questions or concerns about this formulation, please do not hesitate to contact us at Bayview Pharmacy. Our team of compounding pharmacists is well-equipped with the knowledge and expertise to assist you.

This compounded formulation of Estriol/Estradiol [50%/50%] 0.05-0.5 mg/Gm/Progesterone 5-50 mg/Gm is a topical gel designed for precise application on the skin. It is primarily used for the treatment of menopausal symptoms such as hot flashes, night sweats, and vaginal dryness. It can also be beneficial in treating vulvovaginal atrophy, a condition common in postmenopausal women due to decreased estrogen levels.

Additionally, this formulation may be used in the treatment of endometriosis, a condition where tissue that normally lines the uterus grows outside of it. Certain types of breast cancer in premenopausal women may also be treated with this formulation.

However, it is important to note that this formulation should not be used by women who are pregnant or breastfeeding. Women with a history of stroke, blood clots, or liver disease should also avoid using this product. If you are currently taking other medications, such as anticoagulants, it is crucial to consult your healthcare provider before starting this treatment.

The gel should be applied to the affected area once daily, or as directed by your healthcare provider. It is recommended to use the lowest effective dose for the shortest duration of time. Exceeding the recommended dose may increase the risk of side effects.

Common side effects include skin irritation, itching, and redness. If these occur, it is advised to contact your healthcare provider. Rare but serious side effects such as chest pain, shortness of breath, and leg swelling should be treated as medical emergencies and require immediate attention.

If you have any questions or concerns about this formulation, please do not hesitate to reach out to your healthcare provider or pharmacist for further information and guidance.

This topical gel is a compounded formulation of estriol and estradiol, each present in a 50/50 ratio, with concentrations ranging from 0.05-0.5 mg/gm. Additionally, it contains progesterone in concentrations of 5-50 mg/gm. This unique combination is designed to address a variety of health conditions, including menopausal symptoms, endometriosis, and uterine fibroids.

Upon application to the skin, the estriol and estradiol components are absorbed into the bloodstream. These hormones work to alleviate menopausal symptoms such as hot flashes, night sweats, and vaginal dryness. The progesterone component of the gel serves to mitigate the risk of endometrial hyperplasia, a condition that can arise when estrogen levels are excessively high. Furthermore, progesterone aids in reducing the symptoms associated with endometriosis and uterine fibroids.

When utilizing this formulation, adherence to the instructions provided by your healthcare provider is crucial. The gel is typically applied to the skin once or twice daily, depending on the severity of the symptoms. It is essential to apply the gel to clean, dry skin, and to avoid contact with the eyes, nose, and mouth. Washing your hands after applying the gel is also recommended.

If you have any queries regarding this formulation or its application, please do not hesitate to contact us. We are committed to assisting you in finding the most effective treatment for your condition.

This compounded formulation of Estriol/Estradiol [50%/50%] 0.05-0.5 mg/Gm/Progesterone 5-50 mg/Gm Topical Gel is a versatile treatment option for a range of conditions. It is often used in the management of acne, hirsutism, and polycystic ovary syndrome, providing targeted treatment through its easy-to-apply gel consistency. For postmenopausal women undergoing estrogen therapy, this formulation can help reduce the risk of endometrial hyperplasia. It also serves as a preventive measure against osteoporosis in postmenopausal women.

Furthermore, this formulation can be beneficial in addressing symptoms associated with premenstrual syndrome, such as mood swings, irritability, and bloating. It is also used in the treatment of hypoactive sexual desire disorder in women, providing relief and improving overall quality of life. If you have any questions or need further information about the use of this formulation for any of these conditions, please do not hesitate to contact us.